Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine | 245520-69-8 | MFCD12910520 | 99.7% | 371.48 g·mol⁻¹ | C23H25N5 | 10 MG
SDP

Catalog No. 5000287277
Encompass_Preferred

SCH79797 is a research-grade small molecule antagonist of protease-activated receptor 1 (PAR1). It selectively blocks PAR1-mediated signaling in cellular and preclinical models, reducing thrombin-induced responses and enabling studies of platelet aggregation, vascular signaling, and tissue injury mechanisms.

  • Selective PAR1 antagonism with low-nanomolar potency (IC50 ≈ 70 nM)
  • Inhibits thrombin-induced platelet aggregation in vitro
  • Demonstrated antiproliferative and pro-apoptotic effects in preclinical studies
  • Used in vascular, endothelial, and astrocyte signaling research
  • High chemical purity reported (>99.7%)
  • Intended for laboratory research use only

Catalog No. 50-002-87277 Supplier Medchemexpress LLC Supplier No. HY1499310MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SCH79797 is a research-grade small molecule antagonist of protease-activated receptor 1 (PAR1). It selectively blocks PAR1-mediated signaling in cellular and preclinical models, reducing thrombin-induced responses and enabling studies of platelet aggregation, vascular signaling, and tissue injury mechanisms.

  • Selective PAR1 antagonism with low-nanomolar potency (IC50 ≈ 70 nM)
  • Inhibits thrombin-induced platelet aggregation in vitro
  • Demonstrated antiproliferative and pro-apoptotic effects in preclinical studies
  • Used in vascular, endothelial, and astrocyte signaling research
  • High chemical purity reported (>99.7%)
  • Intended for laboratory research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.